grant
Vaccine and Infection Induced Immunity in the Young and Aged
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoVAddressAntigensB blood cellsB cellB cellsB-CellsB-LymphocytesB-cellBiometricsBiometryBiostatisticsBlood SampleBlood specimenCOVID infected patientCOVID patientCOVID positive patientCOVID-19COVID-19 infected patientCOVID-19 infectionCOVID-19 patientCOVID-19 positive patientCOVID-19 virusCOVID-19 virus infectionCOVID19 infectionCOVID19 patientCOVID19 positive patientCOVID19 virusCV-19Cancer CenterCell Mediated ImmunologyCell-Mediated ImmunityCellular ImmunityClinicalCoV-2CoV2Coronavirus Infectious Disease 2019EpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEvolutionGenomicsGoalsHumanHumoral ImmunitiesImmune memoryImmunityImmunologic MemoryImmunological MemoryIndividualInfectionInnate ImmunityInstitutionInvestigatorsMemory B CellMemory B-LymphocyteMessenger RNAModern ManMyeloid CellsNative ImmunityNatural ImmunityNon-Specific ImmunityNonspecific ImmunityPatientsPersonsPost-vaccination infectionResearch PersonnelResearchersSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV-2 infected patientSARS-CoV-2 infectionSARS-CoV-2 patientSARS-CoV-2 positive patientSARS-CoV2SARS-CoV2 infectionSARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SamplingSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome related corona virus 2T cell responseT-CellsT-LymphocyteTimeUniversitiesVaccinationVaccinesViral DiseasesVirus DiseasesWashingtonWuhan coronavirusadaptive immunityage associated effectsage effectage related effectsagedaging effectanalyzing longitudinalanamnestic reactionantibody-based immunitybooster dosebooster shotbooster vaccinebreakthrough infectionclinical research siteclinical sitecohortcoronavirus disease 2019coronavirus disease 2019 infected patientcoronavirus disease 2019 infectioncoronavirus disease 2019 patientcoronavirus disease 2019 positive patientcoronavirus disease 2019 viruscoronavirus disease infected patientcoronavirus disease patientcoronavirus disease positive patientcoronavirus disease-19coronavirus disease-19 patientcoronavirus disease-19 viruscoronavirus infectious disease-19coronavirus patientepigeneticallyhCoV19immune senescenceimmunization strategyimmunogenimmunosenescenceimpact of ageinfected with COVID-19infected with COVID19infected with SARS-CoV-2infected with SARS-CoV2infected with coronavirus disease 2019infected with severe acute respiratory syndrome coronavirus 2influence of ageinsightlongitudinal analysismRNAnCoV2patient infected with COVIDpatient infected with COVID-19patient infected with SARS-CoV-2patient infected with coronavirus diseasepatient infected with coronavirus disease 2019patient infected with severe acute respiratory syndrome coronavirus 2patient with COVIDpatient with COVID-19patient with COVID19patient with SARS-CoV-2patient with coronavirus diseasepatient with coronavirus disease 2019patient with severe acute respiratory distress syndrome coronavirus 2programsrecruitresponsesecondary immune responsesevere acute respiratory syndrome coronavirus 2 infected patientsevere acute respiratory syndrome coronavirus 2 patientsevere acute respiratory syndrome coronavirus 2 positive patientthymus derived lymphocytevaccination strategyvaccine boostviral infectionvirus infectionvirus-induced disease
Description preview
The overarching goal of our CCHI application on “Vaccine and Infection Induced Immunity in the Young and
Aged” is to address fundamental issues about innate and adaptive immunity in humans to infection and
vaccination. Our proposal is focused around a large cohort of > 700 COVID-19 patients that we have been
following for the past 3 years and now…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click